N/A
Completed N=29
FOREward Together: Training Peer Recovery Coaches to Promote Retention and Adherence to MOUD
Source: ClinicalTrials.gov NCT05098795 ↗Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: MOUD Retention Rate — .42 number of days missed MOUD appointment
Summary
This project aims to implement a peer-led intervention to support retention and adherence to medications for opioid use disorder among low-income adults in Detroit, as well as a training manual for peer recovery coaches serving similar populations. The approach will serve as a guide to coaches in providing positive reinforcement and helping those in treatment to schedule and engage in valued activities. Researchers will examine the effectiveness of the intervention, supervision and training models, and share results with policymakers and treatment programs.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY MOUD Retention Rate |
.42 | — |
| PRIMARY Intervention Fidelity: Proportion of Intervention Components Delivered as Intended |
.83 | — |
| SECONDARY Intervention Acceptability: Percentage of Patients Enrolled Who Attend ≥75% Sessions |
62 | — |
| SECONDARY Intervention Feasibility: Percentage of Patients Who Consents Who Started BA |
21 | — |
Eligibility Criteria
Inclusion Criteria
- Participants must (1) be receiving or referred to MOUD; and (2) be over the age of 18.
Exclusion Criteria
- Exclusion criteria will be (1) demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis; or (2) inability to understand the study and give informed consent in English Active, Unstable or Untreated Psychiatric Symptoms: The study team is committed to recruiting a sample that reflects the complexity and likely comorbidity of people with moderate to severe OUD in this setting. Therefore, only people whose concurrent mental health issues preclude ability to participate with the procedures in this study will be excluded. Throughout the study, researchers will monitor for active, unstable or untreated psychiatric symptoms as the presence of these symptoms during study procedures would interfere with participation. Monitoring for exclusionary psychiatric symptoms can include reviewing data in medical chart (per protocol-approved access to medical records), observation during assessments and intervention sessions, and/or current symptoms detected on the MINI modules for psychosis and mania.
Inability to complete informed consent/ study in English. This study/intervention will be implemented in English only. Therefore, the capacity and willingness to give written informed consent in English, to understand the study and inclusion and exclusion criteria in English.
Data sourced from ClinicalTrials.gov (NCT05098795). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.